期刊文献+

端粒酶活性对HeLa细胞生长及化疗敏感性的影响

Effects of Telomerase Activity on Cell Proliferation and Chemosensitivity in Cervix Cancer
下载PDF
导出
摘要 目的研究抑制端粒酶活性对HeLa细胞在体内外生长和对顺铂敏感性的影响。方法将野生型端粒酶逆转录酶、端粒酶逆转录酶显性负突变体和对照质粒电转染于HeLa细胞中,绘制细胞生长曲线,四甲基偶氮唑蓝法(MTT)检测细胞对顺铂的敏感性,磷脂酰丝氨酸外翻分析(Annexin V)法检测细胞凋亡情况;接种裸鼠观察其致瘤性及对顺铂敏感性的影响。结果端粒酶逆转录酶显性负突变体转染于HeLa细胞后,端粒酶活性显著下降,细胞生长速度延缓,显著增强顺铂诱导的凋亡,端粒酶活性抑制后对裸鼠致瘤性丧失,而端粒酶活性增强后顺铂对肿瘤的抑制作用下降。结论端粒酶活性下降能抑制HeLa细胞生长,增强顺铂的杀伤作用,反之端粒酶活性升高将导致对顺铂耐药。 Objective To investigate the effects of telomerase activity on cell proliferation and cytotoxicity of cisplatin in cervix cancer. Methods WT-hTERT, DN-hTERT and control plasmid were electroperated into HeLa cells. Cell growth curves were made by cell counting and cell viability was examined by MTT assay. Annexin V/PI double staining was adopted to confirm apoptosis after treated with cisplatin. Tumorigenicity was evaluated by xenografts. Results After HeLa cells were transfected with DN-hTERT, telomerase activity was inhibited, cell growth slowed down, and cisplatin-induced apoptosis obviously enhanced. The inhibition of telomerase activity resulted in loss of tumorigenicity, while the increased telomerase activity lowered the inhibition rate of cisplatin to tumor. Conclusion Decreased telomerase activity could inhibit cell proliferation and enhance cytotoxicity of cisplatin in cervix cancer. Elevated telomerase activity confers resistance to cisplatin.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第4期521-524,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金(No.30500596) 国家重点基础研究发展规划项目(No.2002CB513100)资助
关键词 端粒酶逆转录酶 宫颈癌 telomerase reverse transcriptase cervix cancer
  • 相关文献

参考文献11

  • 1MEYERSON M,COUNTER C M,EATON E N,et al.hEST2,the putative human telomerase catalytic subunit gene,is up-regulated in tumor cells and immortalization[J].Cell,1997,90(4):785-795.
  • 2NAKAMURA T M,MORIN G B,CHAPMAN K B,et al.Telomerase catalytic subunit homologs from fussion yeast,and human[J].Science,1997,277(5328):955-959.
  • 3SONG J S,KIM H P,YOON W S,et al.Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line[J].Biosci Biotechnol Biochem,2003,67(11):2344-2350.
  • 4奚玲,吴明富,冯永东,王薇,卢运萍,周剑锋,马丁.丁酸钠选择性诱导子宫颈癌细胞凋亡及其机制[J].中国医学科学院学报,2003,25(4):401-405. 被引量:13
  • 5柳洋,文继舫,李景和,肖德胜,胡忠良,罗庚求.DPC4基因转染对结肠癌细胞生长的抑制作用及其作用机制[J].中华病理学杂志,2004,33(3):247-250. 被引量:9
  • 6WILLIAM C H,SHEILA A,STEWAR T,et al.Inhibition of telomerase limits the growth of human cancer cells[J].Nature Med,1999,5(10):1164-1170.
  • 7FOLINI M,PENNATI M,ZAFFARONI N.Targeting human telomerse by antisense oligonucleotides and ribozymes[J].Curr Med Chem-Anti-Cancer Agents,2002,2(5):606-612.
  • 8KRAEMER K,FUESSEL S,SCHMIDT U,et al.Antisense-mediatd hTERT inhibition specifically reduces the growth of human bladder cancer cells[J].Clin Cancer Res,2003,9(10 Pt 1):3794-3800.
  • 9ZHANG X,MAR V,ZHOU W,et al.Telomere shortening and apoptosis in telomerase-inhibited human tumor cells[J].Gene Dev,1999,13(18):2388-2399.
  • 10MISAWA M,TAUCHI T,SASHIDA G,et al.Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells[J].Int J Oncogene,2002,21 (5):1087-1092.

二级参考文献15

  • 1Paul AM, Richard AR, Victoria MR, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev(Cancer), 2001, 1:195-202.
  • 2Myoung SK, Ho JK, You ML, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med, 2001, 7:437-443.
  • 3Weidle UH, Crossmann A. Inhibition of histone deacetylase:a new strategy to target epigenetic modification for anticancer treatment. Anticancer Res, 2000, 20:1471-1479.
  • 4Victoria MR, Todd WS, Richard AR, et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene associated histone acetylation.PNAS,2000, 97:10014-10019
  • 5Patrick F, Christian K, Ubaldo S, et al. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervix carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene, 2001, 20:4768-4776.
  • 6Kwon HI, Kim M, Kim DH. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol, 2003, 36(1):110-119.
  • 7Pier PP. Transcription therapy for cancer. Oncogene, 2001,20:3116-3127.
  • 8Sawa H, Murakami H, Ohshima Y, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. Brain Tumor Pathol, 2001, 18(2):109-114.
  • 9Amin HM, Saeed S, Alkan S. Histone deacetylase inhibitots induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t (15;17).Br J Haematol, 2001, 115(2):287-297.
  • 10Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 1996, 271: 350-353.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部